Clinical Trial: Radiomics-based habitat analysis and deep learning prediction of EGFR and KRAS gene mutation status in non-small cell lung cancer and their response to targeted therapy. (China)

China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Radiomics-based habitat analysis and deep learning prediction of EGFR and KRAS gene mutation status in non-small cell lung cancer and their response to targeted therapy.'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600134159

Registration Time: 2026/10/11

Type: Observational study

Primary Sponsor: First Hospital Of Nanping

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=293525

Published by HT Digital Content Services with permission from Health Daily Digest....